For more information on the GID BIO Osteoarthritis clinical trial click here


The latest GID BIO and cellular therapy news.

Device and cellular therapy could lead to a major development in the treatment of pain and function associated with knee osteoarthritis for 14 million US adults
Individuals who overuse their joints, such as athletes, military members and people working physically demanding jobs are at a high risk of developing knee osteoarthritis (OA), according to the Arthritis Foundation...
Skip to content